MedTrace Logo

Humeral Resurfacing Hemiarthroplasty

NCT00477360 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-08-11

No results posted yet for this study

Summary

The primary objective of this study is to examine quality of life outcomes in patients who have undergone a humeral surface replacement hemiarthroplasty.

Conditions

  • Advanced Glenohumeral Arthritis

Interventions

DEVICE

Humeral surface replacement hemiarthroplasty (CAP)

C.A.P hemiarthroplasty

Sponsors & Collaborators

  • DePuy International

    collaborator INDUSTRY

  • Johnson & Johnson

    collaborator INDUSTRY

  • University of Calgary

    lead OTHER

Principal Investigators

  • Dr. Richard Boorman · University of Calgary

  • Dr. Dianne Bryant · Western University, Canada

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00477360 on ClinicalTrials.gov